ERG-IN-4 (Compound 12) is an orally active, selective ERG inhibitor with an IC50 of 5.2 µM for hERG. ERG-IN-4 activates PXR. ERG-IN-4 exhibits anticancer activity against MTAP-deleted non-small cell lung cancer[1].
Molecular Weight:
497.47
CAS Number:
[3047672-14-7]
Formula:
C24H22F3N7O2
Target:
Potassium Channel,Pregnane X Receptor (PXR)
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted